PT1110551E - Redutor de tensao ocular - Google Patents

Redutor de tensao ocular

Info

Publication number
PT1110551E
PT1110551E PT01102527T PT01102527T PT1110551E PT 1110551 E PT1110551 E PT 1110551E PT 01102527 T PT01102527 T PT 01102527T PT 01102527 T PT01102527 T PT 01102527T PT 1110551 E PT1110551 E PT 1110551E
Authority
PT
Portugal
Prior art keywords
group
alkyl
formula
alkenyl
carboxyl
Prior art date
Application number
PT01102527T
Other languages
English (en)
Inventor
Hiroaki Yanagisawa
Tsunemichi Hosokawa
Tomihisa Yokoyama
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of PT1110551E publication Critical patent/PT1110551E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
PT01102527T 1994-03-16 1995-03-16 Redutor de tensao ocular PT1110551E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4540494 1994-03-16

Publications (1)

Publication Number Publication Date
PT1110551E true PT1110551E (pt) 2004-07-30

Family

ID=12718322

Family Applications (2)

Application Number Title Priority Date Filing Date
PT95912428T PT795326E (pt) 1994-03-16 1995-03-16 Redutor de tensao ocular
PT01102527T PT1110551E (pt) 1994-03-16 1995-03-16 Redutor de tensao ocular

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT95912428T PT795326E (pt) 1994-03-16 1995-03-16 Redutor de tensao ocular

Country Status (20)

Country Link
US (1) US5925664A (pt)
EP (2) EP1110551B1 (pt)
KR (1) KR100211446B1 (pt)
CN (2) CN1104898C (pt)
AT (2) ATE266402T1 (pt)
AU (1) AU684916B2 (pt)
CZ (1) CZ284395B6 (pt)
DE (2) DE69533045T2 (pt)
DK (2) DK1110551T3 (pt)
ES (2) ES2163501T3 (pt)
FI (2) FI114897B (pt)
GR (1) GR3036989T3 (pt)
HK (1) HK1000551A1 (pt)
HU (1) HUT74734A (pt)
MX (1) MX9604109A (pt)
NO (1) NO311068B1 (pt)
NZ (1) NZ282485A (pt)
PT (2) PT795326E (pt)
RU (1) RU2123847C1 (pt)
WO (1) WO1995024902A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0201466A3 (en) * 1999-06-11 2003-04-28 Sankyo Co Ocular tension lowering composition for topical administration
TWI290470B (en) * 1999-12-01 2007-12-01 Sankyo Co The composition for treating glaucoma
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
BRPI0409293A (pt) * 2003-04-15 2006-04-11 Sankyo Co medicamento para a prevenção ou tratamento de doenças angiogênicas intraoculares

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6323868A (ja) * 1986-07-11 1988-02-01 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー アンギオテンシン2受容体遮断性イミダゾ−ル
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
DE69025473T2 (de) * 1989-06-30 1996-10-17 Du Pont Substituierte imidazole und ihre verwendung als hemmmstoff fur angiotensin ii
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
FI112942B3 (fi) * 1991-02-21 2012-03-13 Daiichi Sankyo Co Ltd Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
ATE199548T1 (de) * 1992-06-02 2001-03-15 Sankyo Co 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
JP3501484B2 (ja) * 1992-12-17 2004-03-02 三共株式会社 ビフェニル誘導体
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
AU1423795A (en) * 1994-02-08 1995-08-29 Novartis Ag Treatment of normotensive glaucoma with angiotensin ii antagonists

Also Published As

Publication number Publication date
NZ282485A (en) 1997-06-24
HUT74734A (en) 1997-02-28
DE69533045T2 (de) 2005-01-27
ES2221872T3 (es) 2005-01-16
CN1148809A (zh) 1997-04-30
EP0795326A1 (en) 1997-09-17
NO963854L (no) 1996-11-14
DE69522955T2 (de) 2002-05-29
WO1995024902A1 (fr) 1995-09-21
CN1104898C (zh) 2003-04-09
NO311068B1 (no) 2001-10-08
EP1110551A3 (en) 2001-08-16
CN1202819C (zh) 2005-05-25
DE69533045D1 (de) 2004-06-17
FI963645A (fi) 1996-11-14
AU684916B2 (en) 1998-01-08
RU2123847C1 (ru) 1998-12-27
NO963854D0 (no) 1996-09-13
HK1000551A1 (en) 2002-04-12
DE69522955D1 (de) 2001-10-31
GR3036989T3 (en) 2002-01-31
EP0795326A4 (pt) 1997-09-17
ATE266402T1 (de) 2004-05-15
CZ269496A3 (en) 1996-12-11
EP0795326B1 (en) 2001-09-26
DK0795326T3 (da) 2001-11-26
FI115197B (fi) 2005-03-31
ES2163501T3 (es) 2002-02-01
PT795326E (pt) 2002-01-30
KR100211446B1 (ko) 1999-08-02
CN1387846A (zh) 2003-01-01
EP1110551B1 (en) 2004-05-12
US5925664A (en) 1999-07-20
HU9602534D0 (en) 1996-11-28
KR970701542A (ko) 1997-04-12
MX9604109A (es) 1997-09-30
FI114897B (fi) 2005-01-31
EP1110551A2 (en) 2001-06-27
DK1110551T3 (da) 2004-06-07
FI20041236A (fi) 2004-09-24
CZ284395B6 (cs) 1998-11-11
FI963645A0 (fi) 1996-09-16
AU1960295A (en) 1995-10-03
ATE206050T1 (de) 2001-10-15

Similar Documents

Publication Publication Date Title
DE69331843D1 (de) Xanthine-Derivate als Antidepressiva
GR3019272T3 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
ATE183182T1 (de) S-triazinderivate als lichtschutzmittel
ATE194335T1 (de) 4,5-diaryloxazol-derivate
KR950032169A (ko) 안약 조성물
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
DE69208478D1 (de) Amid derivate von vitamin d
DE69111816D1 (de) Indolederivate und ihre verwendung als serotonin-antagoniste.
DE69717091D1 (de) Oxazole derivate,ihre herstellung und verwendung
ATE252074T1 (de) Phenylalkylcarbonsäure-derivate
ATE421524T1 (de) 5-ring-heterocyclen, ihre herstellung, ihre verwendung als inhibitoren der leukozytenadhäsion und sie enthaltende pharmazeutische präparate
PT1110551E (pt) Redutor de tensao ocular
ATE197297T1 (de) 3-oxo-1,4-benzothiazin-derivate
ATE138914T1 (de) Indeno-d-pyrimidonverbindungen zur verwendung in der medizin
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel